Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Emedastine

Classification: B

Drug products: Emadine

ATC code: S01GX06

Substances: emedastine, emedastine difumarate

Summary

Controlled studies on differences between men and women regarding efficacy, safety and pharmacokinetics of emedastine are lacking.
 
The present evidence concerning differences between men and women is very limited and do not motivate differentiation in dosing or treatment.

Additional information

Pharmacokinetics and dosing

No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of emedastine have been found.

Effects

No studies with a clinically relevant sex analysis regarding the effects of emedastine have been found.

Adverse effects

No studies with a clinically relevant sex analysis regarding the adverse effects of emedastine have been found.

Reproductive health issues

Regarding teratogenic aspects, please consult the Drugs and Birth Defects Database (in Swedish, Janusmed fosterpåverkan).

Updated: 2019-02-26

Date of litterature search: 2015-10-23

References

  1. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.] länk

Authors: Maria Enghag, Desirée Loikas

Reviewed by: Mia von Euler

Approved by: Karin Schenck-Gustafsson